Abstract:Genome-wide association studies (GWASs) have identified dozens of susceptibility loci for sporadic Alzheimer's disease (AD) primarily in Caucasians, but whether the same or different variants account for genetic risks in Chinese remains unknown. A two-stage case-control GWAS was conducted for subjects from 39 hospitals across China. In the discovery stage, 993 AD cases and 6,451 controls passed quality control after genotyping using Illumina HumanOmniZhongHua-8 BeadChips. In the replication stage, 55 top single nucleotide polymorphisms (SNPs) with evidence of associations and eight SNPs previously reported in Caucasians were selected for genotyping using ABI PRISM® SNaPshot™ Multiplex System in an independent cohort of 1,201 AD cases and 4,889 controls. In the combined analysis, seven SNPs had associations exceeding the genome-wide significance threshold (P < 5.0 × 10−8) with no heterogeneity between stages. The overall variance was calculated using the restricted maximum-likelihood method. HaploReg, cis-expression quantitative trait loci (cis-eQTL) database, the Gene Expression Omnibus (GEO) profiles, STRING, and the Gene Ontology enrichment analysis was used to further characterize these seven variants. For the APOE region, multifactor regression analysis using imputed data was performed. Four novel variants were identified with genome-wide significance (P < 5 × 10-8): rs463717 (5q31.3, Pcombined = 8.56 × 10-15), rs11625699 (14q13.1, Pcombined = 4.80 × 10-20), rs3784616 (15q21.1, Pcombined = 2.34 × 10-25), and rs16980322 (19q13.32, Pcombined = 2.75 × 10-21). Additionally, APOE rs405509 (Pcombined = 9.53 × 10-28), PVRL2 rs4803766 (Pcombined = 1.91 × 10-18), and PVRL2 rs387976 (Pcombined = 9.90 × 10-11) were associated with AD. These seven variants explained 15.87% of the overall variance in disease risk. For the eight previously reported SNPs selected for detection in the replication stage, only rs2070045 of SORL1 showed significant associations. Multifactor regression analysis using imputed data in APOE region found previously reported AD-associated SNPs in Caucasians remained significant in Chinese. The present GWAS identified four novel susceptibility variants for AD. The genes located near the four novel variants are functionally related to neurogenesis, suggesting neurogenesis in AD pathogenesis. This study also suggests genetic heterogeneity of AD susceptibility in Chinese and Caucasian populations. Regional association plots. Association results are shown for the analyzed SNPs with recombination rates in the four loci associated with genome-wide significance at 5q31.3 (a), 14q13.1 (b), 15q21.1 (c) and 19q13.32 (d-e). Purple diamonds represent the most significantly associated SNP in the combined analysis. The quantile-quantile (Q-Q) plot of the association results from the discovery stage analysis (993 AD cases and 6,451 controls). Displayed are observed versus expected -log10 P values for all variants. The yellow line indicates the expected distribution of - log10 P values under the null hypothesis. The plot in purple is for SNPs excluding previously reported SNPs with P > 10-12 (λGC = 1.038).

Key variants via the Alzheimer's Disease Sequencing Project whole genome sequence data

FOUR NOVEL SUSCEPTIBILITY VARIANTS IDENTIFIED IN CHINESE ARE ASSOCIATED WITH SPORADIC ALZHEIMER’S DISEASE

Association of common and rare variants with Alzheimer's disease in more than 13,000 diverse individuals with whole‐genome sequencing from the Alzheimer's Disease Sequencing Project

Association of Common and Rare Variants with Alzheimer's Disease in over 13,000 Diverse Individuals with Whole-Genome Sequencing from the Alzheimer's Disease Sequencing Project

Frequency of Variants in Mendelian Alzheimer's Disease Genes within the Alzheimer's Disease Sequencing Project (ADSP)

Structural Variation Detection and Association Analysis of Whole-Genome-Sequence Data from 16,905 Alzheimer's Diseases Sequencing Project Subjects

Variants Near X‐Chromosome Genes NLGN4X and PTCHD1 Are Significantly Associated with Alzheimer’s Disease Risk

Validating Gwas-Identified Risk Loci for Alzheimer'S Disease in Han Chinese Populations

Alzheimer's Disease Sequencing Project Release 4 Whole Genome Sequencing Dataset

Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits

Identification of 16 novel Alzheimer's disease susceptibility loci using multi-ancestry meta-analyses of clinical Alzheimer's disease and AD-by-proxy cases from four whole genome sequencing datasets

Whole Genome Sequencing-Based Copy Number Variations Reveal Novel Pathways and Targets in Alzheimer's Disease.

An association test of the spatial distribution of rare missense variants within protein structures identifies Alzheimer's disease–related patterns

Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease

Genome-wide significant, replicated and functional risk variants for Alzheimer's disease.

Genome-Wide Meta-Analysis of Late-Onset Alzheimer's Disease Using Rare Variant Imputation in 324,809 Subjects Identifies Novel Rare Variant Locus NCK2: The International Genomics of Alzheimer's Project (IGAP)

Association of Rare Variants in Neurodegenerative Genes with Familial Alzheimer's Disease.

Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning

GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia

Beyond association: successes and challenges in linking non-coding genetic variation to functional consequences that modulate Alzheimer's disease risk